Timing of DNA integration, transgenic mosaicism, and pronuclear microinjection

Citation
Aws. Chan et al., Timing of DNA integration, transgenic mosaicism, and pronuclear microinjection, MOL REPROD, 52(4), 1999, pp. 406-413
Citations number
50
Categorie Soggetti
Cell & Developmental Biology
Journal title
MOLECULAR REPRODUCTION AND DEVELOPMENT
ISSN journal
1040452X → ACNP
Volume
52
Issue
4
Year of publication
1999
Pages
406 - 413
Database
ISI
SICI code
1040-452X(199904)52:4<406:TODITM>2.0.ZU;2-4
Abstract
Selection of transgenic embryos prior to embryo transfer is a means to incr ease the efficiency of transgenic livestock production. Among transgenic re porters, cytoplasmic expression of green fluorescent protein (GFP) has feat ures that make it ideal for transgenic embryo selection. The primary object ive of this study was to assess cytoplasmic expression of a specially desig ned GFP reporter as a tool for transgenic bovine embryo selection. A second objective was to evaluate this reporter for studying transgenic mosaicism related to timing of integration of pronuclear microinjected DNA. Transgeni c embryos produced by pronuclear injection showed a discrete pattern of GFP expression with clusters at 25, 50, and 100% of blastomeres expressing GFP . This pattern of mosaicism is interpreted to indicate that the integration of microinjected DNA occurred, not only at the pronuclear stage, but also in the subsequent cell divisions. Among the GFP-positive transgenic embryos , only in 21% did all the blastomeres show the green fluorescence. Using th e fraction of positive blastomeres within an embryo, the timing of integrat ion of microinjected DNA was estimated. The frequency of nonmosaic embryos expressing GFP is consistent with published germline transmission success r ates of transgenic cattle derived from pronuclear microinjected embryos. Th ese results indicate the possible application of GFP as a marker of transge nic embryos and graphically illustrate underlying complexities in DNA integ ration in embryos subjected to pronuclear microinjection. (C) 1999 Wiley-Li ss, Inc.